Michel Hochuli Selected Research

Glycogen Storage Disease Type I

1/2022	Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy.
1/2019	Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.
1/2018	Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
11/2015	Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Hochuli Research Topics

Disease

4	Glycogen Storage Disease Type I 01/2022 - 11/2015
4	Phenylketonurias (Phenylketonuria) 01/2022 - 01/2017
3	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2018
3	Insulin Resistance 01/2021 - 01/2013
2	Adenoma (Adenomas) 01/2022 - 01/2019
2	Metabolic Diseases (Metabolic Disease) 12/2020 - 01/2019
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 07/2015 - 09/2014
1	Renal Insufficiency (Renal Failure) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Methylmalonic acidemia 01/2019
1	Sphingolipidoses (Sphingolipidosis) 11/2018
1	Gaucher Disease (Gaucher's Disease) 11/2018
1	Homocystinuria 01/2017
1	Thromboembolism 01/2017
1	Muscular Diseases (Myopathy) 07/2015
1	Liver Diseases (Liver Disease) 07/2015
1	Propionic Acidemia 09/2014
1	Hepatocellular Carcinoma (Hepatoma) 08/2014
1	Inborn Urea Cycle Disorders 01/2014
1	Inflammation (Inflammations) 08/2011
1	Polycythemia (Erythrocytosis) 01/2009
1	Mucopolysaccharidoses 06/2003

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2011
3	Phenylalanine (L-Phenylalanine)FDA Link 01/2022 - 01/2020
3	FructoseIBA 01/2021 - 01/2013
3	EnzymesIBA 12/2020 - 06/2003
2	GlycogenIBA 01/2022 - 07/2015
2	LipidsIBA 01/2022 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2021
2	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 12/2020
2	Methylmalonyl-CoA MutaseIBA 01/2019 - 09/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	CarbohydratesIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Glucosylceramidase (Glucocerebrosidase)IBA 11/2018
1	HydrolasesIBA 11/2018
1	Insulin (Novolin)FDA Link 01/2018
1	SphingolipidsIBA 01/2018
1	HomocysteineIBA 01/2017
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2017
1	CystathionineIBA 01/2017
1	Amino Acids FDA Link 01/2017
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2017
1	Methionine (L-Methionine)FDA Link 01/2017
1	Starch (Cornstarch)IBA 11/2015
1	Proteins (Proteins, Gene)FDA Link 07/2015
1	Methylmalonic AcidIBA 09/2014
1	Propionyl-Coenzyme A Carboxylase (Propionyl CoA Carboxylase)IBA 09/2014
1	propionic acid (potassium propionate)IBA 09/2014
1	AmmoniaIBA 01/2014
1	Sucrose (Saccharose)IBA 01/2013
1	alpha-GlobinsIBA 01/2009
1	GlycosaminoglycansIBA 06/2003

Therapy/Procedure

3	Glycemic Control 01/2019 - 11/2015
1	Kidney Transplantation 01/2022
1	Pancreas Transplantation 01/2018
1	Islets of Langerhans Transplantation 01/2018
1	Enteral Nutrition (Feeding, Tube) 11/2015
1	Liver Transplantation 08/2014